Potential Formula for the Calculation of Starting and Incremental Insulin Glargine Doses: ALOHA Subanalysis | PLOS ONE
![Table 2 from Switching from biosimilar (Basalin) to originator (Lantus) insulin glargine is effective in Chinese patients with diabetes mellitus: a retrospective chart review | Semantic Scholar Table 2 from Switching from biosimilar (Basalin) to originator (Lantus) insulin glargine is effective in Chinese patients with diabetes mellitus: a retrospective chart review | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/043227ed4e7a1046ef887bf737c977434164c226/6-Table2-1.png)
Table 2 from Switching from biosimilar (Basalin) to originator (Lantus) insulin glargine is effective in Chinese patients with diabetes mellitus: a retrospective chart review | Semantic Scholar
![Evaluation of a Standardized Inpatient Insulin Therapy Based on Electronic Insulin Dose Calculation - A before after Cohort Proof of Concept Study | ClinMed International Library | International Journal of Diabetes and Clinical Research Evaluation of a Standardized Inpatient Insulin Therapy Based on Electronic Insulin Dose Calculation - A before after Cohort Proof of Concept Study | ClinMed International Library | International Journal of Diabetes and Clinical Research](https://clinmedjournals.org/articles/ijdcr/ijdcr-3-060-001.gif)
Evaluation of a Standardized Inpatient Insulin Therapy Based on Electronic Insulin Dose Calculation - A before after Cohort Proof of Concept Study | ClinMed International Library | International Journal of Diabetes and Clinical Research
![Apidra and Lantus Basal Bolus Regimen | Apidra® (insulin glulisine injection) 100 Units/mL | Lantus® (insulin glargine injection) 100 Units/mL Apidra and Lantus Basal Bolus Regimen | Apidra® (insulin glulisine injection) 100 Units/mL | Lantus® (insulin glargine injection) 100 Units/mL](https://www.apidra.com/resources/img/HCP/03_Efficacy/mobile/mobile-chart-common-AEsef10.png?la=en&hash=29372ED3D40323D37D04F90A0691E30161EFB25D)